Arenicolides A (1) and B (2) are 26-membered macrolides with three conjugated dienes and nine chiral centers in the ring. There is one side chain which comprises the C-26 ~ C-36 carbon chain with five consecutive chiral centers. Arenicolide A (1) also showed moderate anti-cancer activity toward the human colon adenocarcinoma cell line HCT-116 (IC50; 30 µg/ mL) and three cell lines in the National Cancer Institute, and no activity against antimicrobial assay using methicillinresistant S. aureus (MRSA) and vancomycinresistant E. faecium (VREF). 1 Arenicolide C (3) was also isolated along with arenicolides A (1) and B (2). And we proposed that the cyclic ether moiety in 3 might be derived biologically from arenicolide A (1) via the acid-catalyzed opening of epoxide and SN2 type addition of the C-33 hydroxyl group. In this paper, we report the stereoselective synthesis of the plausible C-26 ~ C-36 side chain (10) of arenicolide A (1) based on this assumption.
Retrosynthesis is summarized in Scheme 1. The homoallyl chiral center at C-31 of 4 would be introduced by asymmetric allylation of aldehyde. 2 Conformational control from the allylic 1,3-strain and approach of the epoxidizing reagent anti to the methoxy group in 5 should provide the desired stereochemistry of C-30 and C-31 epoxide in 4.
3 Finally, diastereoselective 1,2-syn aldol strategy of α-methoyacetate moiety 6 would be used to construct the C-32 and C-33 chiral centers. 4 The synthesis of target molecule 10 was summarized in Scheme 2. Evans-syn aldol reaction of α-methoyacetate 6 with n-butanal provided the 1,2-syn aldol product in 96% yield, 4 and the free β-hydroxyl group was treated by TBSOTf and 2,6-lutidine to afford the TBS-ether 7 in 84% yield. The chiral auxiliary group of 7 was removed by reduction with LiBH4 in 94% yield, 5 the resulting hydroxyl group was oxidized by Swern oxidation in 91%, yield, and the resulting aldehyde was treated with stabilized Wittig reagent to afford the α,β-unsaturated ester 8 in 92% yield. The ester group of 8 was reduced to primary alcohol by DIBAL in methylene chloride in 94% yield and the diastereselective epoxidation by mCPBA provided the desired epoxide 9 and its isomer in 72%. oxidation of primary alcohol 9 (88%) and chiral-ligand assisted asymmetric allylation of the resulting aldehyde (67%) 2 produced the homoallylic alcohol with the correct stereochemistry at C-29 in 67% yield along with its isomer in 19% yield. Finally, protection of the secondary alcohol with TBSOTf and 2,6-lutidine completed the synthesis of plausible C-26 ~ C-36 side chain moiety (10) of arenicolide A (1).
The origin of diastereoselectivity in the epoxidation reaction can be rationalized by conformational preferences of conformation A over conformation B due to the A 1,3 -strain. 6 In addition, hydroxyl-group directed epoxidation 7 and anti-periplanar approach of the electrophilic oxygen to the best σ-electron acceptor (methoxy group) 8 clearly lead to the desired stereochemistry in 9 through the assembly A-1 over the A-2.
In order to further confirm the relative stereochemical relationship of epoxide 9, the primary hydroxyl group of 9 was converted to the benzyl ether by treatment with sodium hydride and benzyl bromide in THF in 91% yield, and the TBSether was deprotected by TBAF in THF to give the secondary alcohol 11 in 63% yield. After conversion of the secondary alcohol 11 to carbamate 12 by reaction with dimethylcarbamyl chloride in 87% yield, Intramolecular BF3-assisted epoxideopening and cyclization were carried out in methylene chloride to afford the cyclic carbonate 13 in 52% yield.
9 NOE experiment of 13 confirmed the relative stereochemistry of 13 and therefore that of 9, an intermediate in the synthesis of target molecule 10.
10
In summary, the plausible C-26 ~ C-36 side chain 10 of arenicolide A (1) was prepared concisely and efficiently in 10 steps. The key steps are Evans 1,2-syn aldol reaction, diastereoselective epoxidation, and asymmetric allylation of aldehyde.
